•  28
    The Case for Methodological Pluralism in Medical Science
    with Sarah J. L. Edwards, Thomas Bock, Ulo Palm, Glen Cheng, Lixia Wang, and Peter Pitts
    American Journal of Bioethics 20 (9): 39-41. 2020.
    Volume 20, Issue 9, September 2020, Page 39-41.
  •  16
    Recent Case Developments in Health Law
    with Jeremy O. Bressman and Jay S. Reidler
    Journal of Law, Medicine and Ethics 38 (3): 708-716. 2010.
    The False Claims Act, 31 U.S.C. § 3729, a post-Civil War law inspired by cases of defense contracting fraud, was revitalized in 1986. Since then it has been used to sue both manufacturers and providers of pharmaceuticals. In some cases, these suits were meant to target offlabel marketing of pharmaceuticals. In 2009, the 11th Circuit rendered a decision in Hopper v. Solvay Pharmaceuticals that dramatically limits the ability of private plaintiff whistle-blowers to bring qui tam suits under the FC…Read more